Jee et al., 2022 - Google Patents
Maternal regulation of biliary disease in neonates via gut microbial metabolitesJee et al., 2022
View HTML- Document ID
- 5906120383684208663
- Author
- Jee J
- Yang L
- Shivakumar P
- Xu P
- Mourya R
- Thanekar U
- Yu P
- Zhu Y
- Pan Y
- Wang H
- Duan X
- Ye Y
- Wang B
- Jin Z
- Liu Y
- Cao Z
- Watanabe-Chailland M
- Romick-Rosendale L
- Wagner M
- Fei L
- Luo Z
- Ollberding N
- Tang S
- Bezerra J
- Publication year
- Publication venue
- Nature communications
External Links
Snippet
Maternal seeding of the microbiome in neonates promotes a long-lasting biological footprint, but how it impacts disease susceptibility in early life remains unknown. We hypothesized that feeding butyrate to pregnant mice influences the newborn's susceptibility to biliary …
- 201000010099 disease 0 title abstract description 41
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Olm et al. | Robust variation in infant gut microbiome assembly across a spectrum of lifestyles | |
| Wang et al. | Core gut bacteria analysis of healthy mice | |
| Jee et al. | Maternal regulation of biliary disease in neonates via gut microbial metabolites | |
| Su et al. | Diversified gut microbiota in newborns of mothers with gestational diabetes mellitus | |
| Vaughn et al. | Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn's disease | |
| Li et al. | Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn’s disease | |
| Jakobsson et al. | Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section | |
| Huang et al. | Distinct gut microbiota composition and functional category in children with cerebral palsy and epilepsy | |
| Coker et al. | Infant feeding alters the longitudinal impact of birth mode on the development of the gut microbiota in the first year of life | |
| Zhang et al. | The composition and concordance of Lactobacillus populations of infant gut and the corresponding breast-milk and maternal gut | |
| Liu et al. | Fecal transplantation alleviates acute liver injury in mice through regulating Treg/Th17 cytokines balance | |
| CN107949393A (en) | Bacteria composition and its application process | |
| Lundgren et al. | Microbial communities in human milk relate to measures of maternal weight | |
| Kumar et al. | Microbiome as an immunological modifier | |
| Jing et al. | Multi-omics association reveals the effects of intestinal microbiome–host interactions on fat deposition in broilers | |
| Khan et al. | Comparison of microbial populations in the blood of patients with myocardial infarction and healthy individuals | |
| Frugé et al. | Biomarkers associated with tumor Ki67 and cathepsin L gene expression in prostate cancer patients participating in a presurgical weight loss trial | |
| Song et al. | An investigation into the correlation of intestinal flora with obesity and gestational diabetes mellitus | |
| Cao et al. | The gut ileal mucosal virome is disturbed in patients with Crohn’s disease and exacerbates intestinal inflammation in mice | |
| Yuan et al. | Association of gut microbiota and glucose metabolism in children with disparate degrees of adiposity | |
| Liang et al. | Oral probiotics increased the proportion of Treg, Tfr, and Breg cells to inhibit the inflammatory response and impede gestational diabetes mellitus | |
| Deng et al. | Correlation between gut microbiota and the development of Graves’ disease: A prospective study | |
| Li et al. | Intestinal bacteroides sp. imbalance associated with the occurrence of childhood undernutrition in China | |
| Gala et al. | Alterations in the stool microbiome in newborns undergoing mild therapeutic hypothermia after hypoxic-ischemic encephalopathy | |
| Tubau-Juni et al. | Identification of new regulatory genes through expression pattern analysis of a global RNA-seq dataset from a Helicobacter pylori co-culture system |